- Home
- TSHA vs MPB Comparison
TSHA vs MPB Comparison
Compare TSHA & MPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- MPB
- Stock Information
- Founded
- TSHA 2019
- MPB 1868
- Country
- TSHA United States
- MPB United States
- Employees
- TSHA N/A
- MPB N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- MPB Major Banks
- Sector
- TSHA Health Care
- MPB Finance
- Exchange
- TSHA Nasdaq
- MPB Nasdaq
- Market Cap
- TSHA 397.8M
- MPB 467.7M
- IPO Year
- TSHA 2020
- MPB N/A
- Fundamental
- Price
- TSHA $2.71
- MPB $26.65
- Analyst Decision
- TSHA Strong Buy
- MPB Buy
- Analyst Count
- TSHA 7
- MPB 2
- Target Price
- TSHA $7.00
- MPB $36.00
- AVG Volume (30 Days)
- TSHA 5.2M
- MPB 86.0K
- Earning Date
- TSHA 05-15-2025
- MPB 07-23-2025
- Dividend Yield
- TSHA N/A
- MPB 3.00%
- EPS Growth
- TSHA N/A
- MPB 23.94
- EPS
- TSHA N/A
- MPB 2.88
- Revenue
- TSHA $7,224,000.00
- MPB $181,865,000.00
- Revenue This Year
- TSHA N/A
- MPB $24.31
- Revenue Next Year
- TSHA N/A
- MPB $13.74
- P/E Ratio
- TSHA N/A
- MPB $9.26
- Revenue Growth
- TSHA N/A
- MPB 9.21
- 52 Week Low
- TSHA $1.05
- MPB $20.03
- 52 Week High
- TSHA $4.32
- MPB $33.87
- Technical
- Relative Strength Index (RSI)
- TSHA 60.38
- MPB 41.02
- Support Level
- TSHA $2.44
- MPB $26.18
- Resistance Level
- TSHA $2.95
- MPB $27.60
- Average True Range (ATR)
- TSHA 0.25
- MPB 0.53
- MACD
- TSHA -0.02
- MPB -0.27
- Stochastic Oscillator
- TSHA 51.60
- MPB 15.31
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.